Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Article in English | MEDLINE | ID: mdl-37868681

ABSTRACT

Eosinophilic granulomatosis with polyangiitis (EGPA) also referred to as Churg-Strauss syndrome is a rare vasculitis of the small to medium vessels. We present a rare case of acute coronary artery dissection brought on by EGPA, which generally has a poor prognosis. A 41-year-old male with history of bronchial asthma presented to the emergency room with a 2-week history of dyspnea, cough with clear phlegm, and fever. For the past eight months he had experienced episodes with similar symptoms relieved by steroids. CT chest showed bilateral upper lobe patchy opacities with extensive workup for infectious etiology being negative. He had peripheral eosinophilia with sinusitis. He had acute coronary syndrome and Coronary angiogram showed Right coronary artery dissection. After making a diagnosis of EGPA based on American college of Rheumatology criteria, he was successfully treated with high dose immunosuppression. Coronary artery dissection is a fatal and uncommon complication of EGPA which is usually diagnosed postmortem. Early recognition of this condition ante mortem and aggressive treatment can be lifesaving as demonstrated in our case.

2.
Soft Robot ; 10(3): 660-672, 2023 Jun.
Article in English | MEDLINE | ID: mdl-36648397

ABSTRACT

Inchworm-inspired bionic soft crawling robot (SCR) composed of soft materials possesses preeminent active compliant deformation ability and has obvious advantages over traditional hard robots when moving in a confined space, which is up-and-coming candidate in robotic community. Nevertheless, there are rare investigations on dynamic modeling problems of the SCR allowing for its nonlinear deformation properties and frictional contact that affects its crawling performance. In view of this, within the theoretical framework of absolute nodal coordinate formulation, in consideration of material, geometry, and boundary nonlinearities, combining a multiple-point contact model with the Coulomb friction model, an effective and accurate nonlinear dynamic model for a bioinspired SCR with one single limb is proposed to elucidate its motion law. We implement an in-depth dynamic research and analysis on the SCR in terms of average velocity, stick-slip characteristic, gaits and successfully simulate its successive forward crawling locomotion meanwhile gaining dynamic response. The proposed theoretical dynamic model correctly captures the SCR' complex geometry configurations and nonlinear deformations, discloses its stick-slip dynamic behaviors and crawling locomotion mechanism, whose effectiveness and superiority are validated experimentally, which inspires a deep insight to motion analysis of other types of soft robots, and enlightens new ideas of their diversified architecture designs.


Subject(s)
Robotics , Locomotion/physiology , Gait/physiology , Models, Theoretical , Motion
3.
Cell Death Dis ; 10(12): 873, 2019 11 18.
Article in English | MEDLINE | ID: mdl-31740661

ABSTRACT

Esophageal squamous cell carcinoma (ESCC) remains one of the most common malignancies in China and has a high metastasis rate and poor prognosis. Cancer-associated fibroblasts (CAFs), a prominent component of the tumor microenvironment, can affect tumor progression and metastasis, but the underlying mechanism remains unclear. There are no studies that explore the role of hydrogen peroxide-inducible clone 5 (HIC-5) in ESCC or compare the role of HIC-5 in CAFs and adjacent noncancerous normal fibroblasts (NFs). In this study, we isolated primary CAFs and NFs from ESCC patients. HIC-5 was highly expressed in CAFs from the tumor stroma of human ESCC patients. HIC-5 knockdown in CAFs inhibited the migration and invasion of ESCC cells in vitro. Supernatant CCL2 levels of CAFs were significantly higher after TGF-ß stimulation and lower after knocking down HIC-5 expression, independent of TGF-ß treatment. HIC-5 knockdown in CAFs led xenograft tumors derived from ESCC cells mixed with CAFs to present more regular morphology, express higher CDH1, and lower CCL2. Further RNA-seq data showed that HIC-5 has distinct biological functions in CAFs vs. NFs, especially in cell movement and the Rho GTPase signaling kinase pathway, which was verified by wound-healing assays and western blotting. An ESCC tissue microarray revealed that increased HIC-5 expression in the tumor stroma was associated with positive lymph node metastasis and a higher TNM stage. In summary, we identified that stromal HIC-5 was a predictive risk factor for lymph node metastasis in human ESCC and that CAF-derived HIC-5 regulated ESCC cell migration and invasion by regulating cytokines and modifying the ECM.


Subject(s)
Cancer-Associated Fibroblasts/metabolism , Esophageal Neoplasms/metabolism , Esophageal Squamous Cell Carcinoma/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , LIM Domain Proteins/metabolism , Animals , Cancer-Associated Fibroblasts/pathology , Cell Line, Tumor , Cell Movement/physiology , Cytokines/metabolism , Disease Progression , Esophageal Neoplasms/pathology , Esophageal Squamous Cell Carcinoma/pathology , Female , Heterografts , Humans , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Middle Aged , Tumor Microenvironment
4.
Cell Cycle ; 17(13): 1614-1623, 2018.
Article in English | MEDLINE | ID: mdl-29962275

ABSTRACT

The human immunodeficiency virus-1 (HIV-1) regulatory protein Tat plays an important role during HIV-1-associated neurocognitive disorders (HAND) by inducing neuronal autophagy. In this study, we used immunohistochemistry, immunofluorescence, western blot, qRT-PCR, and RNA interference to elucidate the involvement of Bcl-2-associated athanogene 3 (BAG3) in the pathogenesis of HIV-1 Tat-induced autophagy during HAND. We found that BAG3 expression is elevated in astrocytes in frontal cortex of macaques infected with simian immunodeficiency virus-human immunodeficiency chimeric virus (SHIV). In addition, in human primary glioblastoma cells (U87), HIV-1 Tat upregulated BAG3 in an NF-κB-dependent manner to induce autophagy. Importantly, suppression of BAG3 or inhibition of NF-κB activity reversed the HIV-1 Tat-induced autophagy. These results indicate that HIV-1 Tat induces autophagy by upregulating BAG3 via NF-κB signaling, which suggests BAG3 and NF-κB could potentially serve as novel targets for HAND therapies.


Subject(s)
AIDS Dementia Complex/pathology , Adaptor Proteins, Signal Transducing/metabolism , Apoptosis Regulatory Proteins/metabolism , Autophagy , HIV-1/metabolism , NF-kappa B/metabolism , Signal Transduction , tat Gene Products, Human Immunodeficiency Virus/metabolism , Adaptor Proteins, Signal Transducing/genetics , Animals , Apoptosis Regulatory Proteins/genetics , Astrocytes/metabolism , Astrocytes/virology , Cell Line, Tumor , Female , Macaca , Male , RNA, Viral/metabolism , Up-Regulation/genetics
5.
Int J Infect Dis ; 68: 1-3, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29292042

ABSTRACT

The case of a Chinese patient with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP), who showed typical neurological symptoms of the disease, is reported here. Since the presence of anti-HTLV-1 antibody was not investigated, this patient's diagnosis of HAM/TSP was delayed for 4 years. Magnetic resonance imaging revealed multiple spotty lesions in the cervical spinal cord, probably reflecting pathological changes known as perivascular lymphocytic infiltrations of the spinal cord. As this is the first case report of a HAM/TSP patient in China, it is suggested that serological testing for HTLV-1 should be considered in patients with spastic paraparesis even in areas that are non-endemic for HTLV-1.


Subject(s)
Nervous System Diseases/diagnosis , Paraparesis, Tropical Spastic/pathology , Spinal Cord/physiopathology , Administration, Intravenous , Administration, Oral , Antibodies, Viral/blood , Asian People , China , Female , Human T-lymphotropic virus 1/isolation & purification , Humans , Lower Extremity/physiopathology , Magnetic Resonance Imaging , Methylprednisolone/therapeutic use , Middle Aged , Nervous System Diseases/blood , Nervous System Diseases/drug therapy , Paraparesis, Tropical Spastic/diagnosis , Prednisolone/therapeutic use
6.
Oncotarget ; 8(24): 39922-39934, 2017 Jun 13.
Article in English | MEDLINE | ID: mdl-28404980

ABSTRACT

During HIV-associated neurocognitive disorder (HAND), decreasing in excitatory amino acid transporter 2 (EAAT-2) in astrocyte plasma membranes leads to elevated levels of extracellular glutamate and, in turn, neuronal apoptosis. We used immunohistochemistry, western blot, qRT-PCR, and RNA interference to elucidate the molecular mechanisms underlying the decreased EAAT-2 expression during HAND at the tissue and cellular levels. We used simian immunodeficiency virus-human immunodeficiency virus chimeric virus (SHIV)-infected macaques as an in vivo model of HAND. Our results show that EAAT-2 expression was decreased in the cerebral cortex, while AEG-1 expression was increased, and the expression levels of these proteins were negatively correlated. In vitro analyses showed that HIV-1 Tat inhibited EAAT-2 expression by inducing overexpression of AEG-1. More specifically, HIV-1 Tat increased AEG-1 expression via the PI3-K signaling pathway, while increasing EAAT-2 inhibition by YinYan-1 (YY-1) via the NF-κB signaling pathway. These results warrant testing AEG-1 as a potential therapeutic target for treating HAND.


Subject(s)
Cell Adhesion Molecules/metabolism , Glutamate Plasma Membrane Transport Proteins/antagonists & inhibitors , HIV Infections/physiopathology , HIV-1/pathogenicity , Neurocognitive Disorders/pathology , tat Gene Products, Human Immunodeficiency Virus/pharmacology , Excitatory Amino Acid Transporter 2 , HIV Infections/virology , Humans , Membrane Proteins , Neurocognitive Disorders/epidemiology , Neurocognitive Disorders/metabolism , Neurocognitive Disorders/virology , RNA-Binding Proteins , Up-Regulation
7.
Oncotarget ; 8(11): 18082-18094, 2017 Mar 14.
Article in English | MEDLINE | ID: mdl-28178646

ABSTRACT

The molecular mechanisms involved in human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND) remain poorly understood. It has been recently reported that HIV-1 Tat transactivation requires menin, suggesting that menin may be involved in HAND pathogenesis. But the role of menin is not clear. Here, we found that protein level of menin was increased in simian-human immunodeficiency chimeric virus (SHIV)-SF162.P4 and simian immunodeficiency virus (SIV) sm543-3-infected rhesus macaques compared with the controls by immunohistochemistry (IHC) and western blot. Menin mainly expressed in the frontal cortex neurons of the brain, more importantly, the number of menin-staining cells was positively correlated with cleaved-caspase-3-positive cells while it was negatively correlated with a neuron-specific nuclear protein NeuN-positive cells, suggesting that expression of menin may induce neuronal apoptosis. Further studies showed that menin level was significantly increased during Tat-induced apoptosis, while downregulation of menin by pll3.7-MEN1-shRNA attenuated the Tat-induced cleavage of caspase-3 and caspase-8 in SY5Y cells and primary neuron cultures. Together, our findings reveal a pro-apoptotic role of menin in the brains of the SIV-infected macaques and the cultured neurons, indicating that targeting menin may be potential to block the HIV-1 Tat induced neuronal damage in HAND.


Subject(s)
Frontal Lobe/virology , Multiple Endocrine Neoplasia Type 1/metabolism , Neurons/pathology , Simian Acquired Immunodeficiency Syndrome/metabolism , tat Gene Products, Human Immunodeficiency Virus/metabolism , AIDS Dementia Complex , Animals , Apoptosis/physiology , Blotting, Western , Cell Line , Female , Fluorescent Antibody Technique , Frontal Lobe/metabolism , Frontal Lobe/pathology , Humans , Immunohistochemistry , In Situ Nick-End Labeling , Macaca mulatta , Mice , Mice, Inbred C57BL , Neurons/metabolism , Simian Acquired Immunodeficiency Syndrome/pathology
8.
Neuropathology ; 37(1): 25-34, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27506782

ABSTRACT

Human immunodeficiency virus (HIV) encephalitis and degeneration of cerebral cortex are established histopathologies of HIV-associated neurocognitive disorders (HAND). We previously reported decreased excitatory amino acid transporter-2 (EAAT-2) and astrocytic apoptosis in cortical degeneration using SIVmac239 and simian-human immunodeficiency virus (SHIV)-infected macaques and human AIDS autopsy cases. In the present study, we added highly pathogenic SIVsm543-3-infected macaques. These animals showed similar degenerative changes in the frontal cortex. Using 11 SIV-infected macaques, three SIVsm543-3, five SIVmac239 and three SHIV, we compared brain pathology caused by three different viruses and further analyzed the pathogenic process of HAND. We noticed vacuolar changes in perivascular processes of astrocytes by electron microscopy, and examined expression of astrocyte-specific protein aquaporin-4 (AQP4) by immunohistochemistry. APQ4 was diffusely positive in the neuropil and perivascular area in control brains. There was patchy or diffuse decrease of AQP4 staining in the neuropil of SIV-infected macaques, which was associated with EAAT-2 staining by double immunostaining. A quantitative analysis demonstrated significant positive correlation between areas of AQP4 and EAAT-2. Some astrocytes express EAAT-2 but not AQP4, and decrease of EAAT-2 expression tended to be less than the decrease of AQP4. Active-caspase-3 immunostaining demonstrated apoptosis of neurons and astrocytes in the area of AQP4/EAAT-2 reduction. These results suggest that AQP4 is damaged first and decrease of EAAT-2 may follow in pathogenesis of cortical degeneration. This is the first demonstration of decrease of AQP4 and its association with EAAT-2 decrease in AIDS brain, suggesting a role in the pathogenesis of HAND.


Subject(s)
AIDS Dementia Complex/metabolism , Aquaporin 4/metabolism , Astrocytes/metabolism , Brain/metabolism , Excitatory Amino Acid Transporter 2/metabolism , AIDS Dementia Complex/pathology , Animals , Apoptosis/physiology , Astrocytes/pathology , Brain/pathology , Caspase 3/metabolism , Female , Macaca mulatta , Male , Neurons/metabolism , Neurons/pathology , Neuropil/metabolism , Neuropil/pathology , Simian Immunodeficiency Virus
9.
Acta Pharmacol Sin ; 36(10): 1256-65, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26190500

ABSTRACT

AIM: To investigate the effects of 3,4,4'-trihydroxy-trans-stilbene (3,4,4'-THS), an analogue of resveratrol, on human non-small-cell lung cancer (NSCLC) cells in vitro. METHODS: Cell viability of NSCLC A549 cells was determined by MTT assay. Cell apoptosis was evaluated using flow cytometry and TUNEL assay. Cell necrosis was evaluated with LDH assay. The expression of apoptosis- or autophagy-associated proteins was measured using Western blotting. The formation of acidic compartments was detected using AO staining, neutral red staining and Lysotracker-Red staining. LC3 punctae were analyzed with fluorescence microscopy. RESULTS: Treatment with 3,4,4'-THS (10-80 µmol/L) concentration-dependently inhibited the cell viability. It did not cause cell necrosis, but induced apoptosis accompanied by up-regulation of cleavaged PARP, caspase3/9 and Bax, and by down-regulation of Bcl-2 and surviving. It also increased the formation of acidic compartments, LC3-II accumulation and GFP-LC3 labeled autophagosomes in the cells. It inhibited the mTOR-dependent pathway, but did not impair autophagic flux. 3,4,4'-THS-induced cell death was enhanced by the autophagy inhibitors 3-MA (5 mmol/L) or Wortmannin (2 µmol/L). Moreover, 3,4,4'-THS treatment elevated the ROS levels in the cells, and co-treatment with 3-MA further elevated the ROS levels. 3,4,4'-THS-induced apoptosis and autophagy in the cells was attenuated by NAC (10 mmol/L)Conclusion:3,4,4'-THS induces both apoptosis and autophagy in NSCLC A549 cells in vitro. Autophagy inhibitors promote 3,4,4'-THS-induced apoptosis of A549 cells, thus combination of 3,4,4'-THS and autophagy inhibitor provides a promising strategy for NSCLC treatment.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Autophagy/drug effects , Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/drug therapy , Stilbenes/pharmacology , Carcinoma, Non-Small-Cell Lung/metabolism , Carcinoma, Non-Small-Cell Lung/pathology , Cell Line, Tumor , Humans , Lung/drug effects , Lung/metabolism , Lung/pathology , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Reactive Oxygen Species/metabolism , Signal Transduction/drug effects , TOR Serine-Threonine Kinases/metabolism
10.
BMC Struct Biol ; 14: 26, 2014 Dec 20.
Article in English | MEDLINE | ID: mdl-25526801

ABSTRACT

BACKGROUND: Hirudin is an anti-coagulation protein produced by the salivary glands of the medicinal leech Hirudomedicinalis. It is a powerful and specific thrombin inhibitor. The novel recombinant hirudin, RGD-hirudin, which contains an RGD motif, competitively inhibits the binding of fibrinogen to GPIIb/IIIa on platelets, thus inhibiting platelet aggregation while maintaining its anticoagulant activity. RESULTS: Recombinant RGD-hirudin and six mutant variants (Y3A, S50A, Q53A, D55A, E57A and I59A), designed based on molecular simulations, were expressed in Pichia pastoris. The proteins were refolded and purified to homogeneity as monomers by gel filtration and anion exchange chromatography. The anti-thrombin activity of the six mutants and RGD-hirudin was tested. Further, we evaluated the binding of the mutant variants and RGD-hirudin to thrombin using BIAcore surface plasmon resonance analysis (SPR). Kinetics and affinity constants showed that the KD values of all six mutant proteins were higher than that of RGD-hirudin. CONCLUSIONS: These findings contribute to a novel understanding of the interaction between RGD-hirudin and thrombin.


Subject(s)
Hirudins/chemistry , Hirudins/genetics , Pichia/genetics , Thrombin/antagonists & inhibitors , Tyrosine/genetics , Binding Sites , Catalytic Domain , Hirudins/pharmacology , Models, Molecular , Molecular Docking Simulation , Pichia/metabolism , Point Mutation , Protein Refolding , Surface Plasmon Resonance , Thrombin/metabolism
11.
Acta Pharmacol Sin ; 34(9): 1174-82, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23770989

ABSTRACT

AIM: Trans-3,4,5,4'-tetramethoxystilbene (DMU-212) has shown strong antiproliferative activities against a variety of cancer cells. The aim of this study was to investigate the anti-angiogenic effects of DMU-212 in vitro and in vivo. METHODS: Human umbilical vein endothelial cells (HUVECs) were used in this study. Cell viability was studied with MTT assay, and cell apoptosis was evaluated using TUNEL assay and morphological observation. The expression of the related genes and proteins was analyzed with qRT-PCR and Western blot, respectively. Angiogenesis of HUVECs were studied using cell migration and capillary-like tube formation assays in vitro, and mouse Matrigel plug assay and chick chorioallantoic membrane (CAM) assay in vivo. The tyrosine kinase activities of VEGFR1 and VEGFR2 were measured using commercial kits. RESULTS: DMU-212 (5-80 µmol/L) significantly inhibited VEGF-stimulated proliferation of HUVECs (IC50 value was approximately 20 µmol/L), and induced apoptosis. Furthermore, DMU-212 concentration-dependently inhibited VEGF-induced migration of HUVECs and capillary-like structure formation in vitro. DMU-212 also inhibited VEGF-induced generation of new vasculature in Matrigel plugs in vivo with significantly decreased area of infiltrating CD31-positive endothelial cells, and inhibited newly formed microvessels in chick CAMs. Moreover, DMU-212 concentration-dependently suppressed VEGF-induced phosphorylation of VEGFR2, and inhibited phosphorylation of multiple downstream signaling components in the VEGFR2 pathway, including c-Src, FAK, Erk1/2, Akt, mTOR, and p70S6K in HUVECs. DMU-212 had no effect on VEGF-induced phosphorylation of VEGFR1. CONCLUSION: DMU-212 is a potent inhibitor of angiogenesis that exerts anti-angiogenic activity at least in part through the VEGFR2 signaling pathway.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Human Umbilical Vein Endothelial Cells/drug effects , Neovascularization, Physiologic/drug effects , Stilbenes/pharmacology , Angiogenesis Inhibitors/chemistry , Animals , Cell Movement/drug effects , Cell Movement/physiology , Chick Embryo , Dose-Response Relationship, Drug , Human Umbilical Vein Endothelial Cells/physiology , Humans , Mice , Mice, Inbred C57BL , Neovascularization, Physiologic/physiology , Resveratrol , Stilbenes/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...